James Cox is the visionary CEO and Founder of BioTalent, a company he launched in 2018 to revolutionise STEM recruitment. With a passion for science, sales, and connecting exceptional talent with pioneering organisations, James has led BioTalent to become a trusted partner in the life sciences sector. His leadership is defined by a commitment to innovation, excellence, and fostering growth within the global STEM landscape.
Before founding BioTalent, James honed his expertise at Hobson Prior, where he achieved record-breaking permanent billings and played a pivotal role in expanding the Acacium Group's global footprint. In 2023, James spearheaded BioTalent’s acquisition by The IN Group, creating a global specialist division with over 60 experts dedicated to solving the talent shortage in life sciences.
Outside of work, James cherishes time with his wife and two young children. A sports enthusiast, he’s often found on the tennis court, skiing down mountains, or capturing moments as a passionate amateur photographer - a craft he once pursued professionally, with his work featured in Red Bull publications and F1 events.
Blogs by James
Why the seed funding slowdown is a talent problem, not just a funding one.
Seed funding in life sciences is down 44% year on year, and BioTalent explains why that funding gap points to a hiring gap a few years out.
The biotech market is back. The early-stage ecosystem isn't
BioTalent CEO James Cox analyses 14 months of biopharma financing data, revealing a widening gap between late-stage capital and early-stage funding.
BioTalent launches BioX: Executive search built for life sciences leadership
BioTalent launches BioX, a dedicated executive search service for life sciences, delivering 98.9% one-year retention and a fixed-fee model.
NPS Score
70+ is considered world-class
76
Get in touch
Whether you're hiring or job hunting, we're here to make the process simple. Reach out and let's talk.
All Rights Reserved 2026 BioTalent
